Sandbox testing: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Label_Template
{{Label_template
|drugClass=thienopyridine
|drugClass=thienopyridine
|indication=ACS
|indication=ACS

Latest revision as of 20:25, 18 March 2014

Sandbox testing®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Routes and Preparations
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]{{{authorTag}}}

For information about {{{genericName}}}, click here.

Disclaimer

Overview

Sandbox testing is a thienopyridine drug that is FDA approved for the treatment of ACS. Adverse reactions include increased risk of bleeding.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)
Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)
Off-Label Use and Dosage (Pediatric)

Contraindications

Warnings

Adverse Reactions

Clinical Trials Experience
Postmarketing Experience

Drug Interactions

Use in Specific Populations

Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Geriatric Use
Gender
Race
Renal Impairment
Hepatic Impairment
Females of Reproductive Potential and Males
Immunocompromised Patients

Routes and Preparations

Routes
Preparations

IV Compatibility

Overdosage

Pharmacology

Mechanism of Action
Structure
Pharmacodynamics
Pharmacokinetics
Nonclinical Toxicology

Clinical Studies

How Supplied

Images

Drug Images
Package and Label Display Panel

Patient Information

Patient Information from FDA

Patient Information from NLM

Look-Alike Drug Names

Price

Drug Shortage